Patients with hypertrophic cardiomyopathy (HCM) who have left ventricular outflow tract obstruction (LVOTO) often experience severe symptoms and functional limitation. Relief of LVOTO can be achieved by two invasive interventions, i.e., surgery myectomy and alcohol septal ablation (ASA), leading in experienced hands to a dramatic improvement in clinical status. Despite extensive research, however, the choice of the best option in individual patients remains challenging and poses numerous clinical dilemmas.
Septal ablation versus surgical myomectomy for hypertrophic obstructive cardiomyopathy / Pelliccia, F; Seggewiss, H; Cecchi, F; Calabrò, P; Limongelli, G; Alfieri, O; Ferrazzi, P; Yacoub, M H; Olivotto, I. - In: CURRENT CARDIOLOGY REPORTS. - ISSN 1523-3782. - 23:11(2021). [10.1007/s11886-021-01600-5]
Septal ablation versus surgical myomectomy for hypertrophic obstructive cardiomyopathy
Pelliccia, F
;Limongelli, G;
2021
Abstract
Patients with hypertrophic cardiomyopathy (HCM) who have left ventricular outflow tract obstruction (LVOTO) often experience severe symptoms and functional limitation. Relief of LVOTO can be achieved by two invasive interventions, i.e., surgery myectomy and alcohol septal ablation (ASA), leading in experienced hands to a dramatic improvement in clinical status. Despite extensive research, however, the choice of the best option in individual patients remains challenging and poses numerous clinical dilemmas.| File | Dimensione | Formato | |
|---|---|---|---|
|
Pelliccia_Septal_2021.pdf
accesso aperto
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
988.04 kB
Formato
Adobe PDF
|
988.04 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
